Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies

about

Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies

Item

http://www.wikidata.org/entity/Q41475920

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Depletion of nerve growth fact ...... with hematologic malignancies

@en

type

Item

label

Depletion of nerve growth fact ...... with hematologic malignancies

@en

prefLabel

Depletion of nerve growth fact ...... with hematologic malignancies

@en

P1476

Depletion of nerve growth fact ...... with hematologic malignancies

@en

P2093

Dong-Yeop Shin

http://www.w3.org/2001/XMLSchema#string

Jeonghwan Youk

http://www.w3.org/2001/XMLSchema#string

Jung-Ah Lim

http://www.w3.org/2001/XMLSchema#string

Young-Sook Kim

http://www.w3.org/2001/XMLSchema#string

Youngil Koh

http://www.w3.org/2001/XMLSchema#string

P2860

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.

Anti-nerve growth factor in pain management: current evidence

Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

Chemotherapy-induced peripheral neurotoxicity: a critical analysis

Pain assessment: global use of the Brief Pain Inventory

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

International uniform response criteria for multiple myeloma.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR

P304

e0183491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0183491

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Soon-Tae Lee

Inho Kim

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28827818

http://www.w3.org/2001/XMLSchema#string

P932

5565270

http://www.w3.org/2001/XMLSchema#string